Transcriptomic Profiling Reveals Underlying Immunoregulation Mechanisms of Resistant Hypertension in Injection Drug Users

References

• Zhou B, Perel P, Mensah GA, et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(1):1–18. doi:10.1038/s41569-020-00473-5
   PubMed Web of Science ®Google Scholar
• Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest. 2006;130(6):1657–1663. doi:10.1378/chest.130.6.1657
   PubMed Web of Science ®Google Scholar
• Darke S, Duflou J, Kaye S. Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study. Drug Alcohol Depend. 2017;179:174–179. doi:10.1016/j.drugalcdep.2017.07.001
   PubMed Web of Science ®Google Scholar
• Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharmacol. 2019;176(12):1818–1828. doi:10.1111/bph.14427
   PubMed Web of Science ®Google Scholar
• Kossmann S, Schwenk M, Hausding M, et al. Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells. Arterioscler Thromb Vasc Biol. 2013;33(6):1313–1319. doi:10.1161/ATVBAHA.113.301437
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Q, Wu H, et al. Blood neutrophil to lymphocyte ratio as a predictor of hypertension. Am J Hypertens. 2015;28(11):1339–1346. doi:10.1093/ajh/hpv034
   PubMed Web of Science ®Google Scholar
• Zhang RM, McNerney KP, Riek AE, Bernal-Mizrachi C. Immunity and hypertension. Acta Physiol. 2021;231(1):e13487. doi:10.1111/apha.13487
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204(10):2449–2460. doi:10.1084/jem.20070657
   PubMed Web of Science ®Google Scholar
• Lv D, Zhang M, Jin X, et al. The body mass index, blood pressure, and fasting blood glucose in patients with methamphetamine dependence. Medicine. 2016;95(12):e3152. doi:10.1097/MD.0000000000003152
   PubMed Web of Science ®Google Scholar
• Potula R, Haldar B, Cenna JM, Sriram U, Fan S. Methamphetamine alters T cell cycle entry and progression: role in immune dysfunction. Cell Death Discov. 2018;4(1):44. doi:10.1038/s41420-018-0045-6
   PubMed Web of Science ®Google Scholar
• Talloczy Z, Martinez J, Joset D, et al. Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 2008;4(2):e28. doi:10.1371/journal.ppat.0040028
   PubMed Web of Science ®Google Scholar
• Mata MM, Napier TC, Graves SM, Mahmood F, Raeisi S, Baum LL. Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse. Eur J Pharmacol. 2015;752:26–33. doi:10.1016/j.ejphar.2015.02.002
   PubMed Web of Science ®Google Scholar
• Hansen W, Luppus S, Barthel R, et al. Heroin-assisted treatment of heroin-addicted patients normalizes regulatory T cells but does not restore CD4(+) T cell proliferation. Addict Biol. 2021;26(4):e12998. doi:10.1111/adb.12998
   PubMed Web of Science ®Google Scholar
• Xinzhi W. New diagnostic and therapeutic criteria for hypertension. Chin J Med. 1979;4(10):62–63.
   Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Miao YR, Zhang Q, Lei Q, et al. ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci. 2020;7(7):1902880. doi:10.1002/advs.201902880
   Web of Science ®Google Scholar
• Hernandez-Santini AC, Mitha AN, Chow D, et al. Methamphetamine facilitates pulmonary and splenic tissue injury and reduces T cell infiltration in C57BL/6 mice after antigenic challenge. Sci Rep. 2021;11(1):8207. doi:10.1038/s41598-021-87728-4
   PubMed Web of Science ®Google Scholar
• Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–2725. doi:10.1111/bph.13750
   PubMed Web of Science ®Google Scholar
• Higaki A, Caillon A, Paradis P, Schiffrin EL. Innate and innate-like immune system in hypertension and vascular injury. Curr Hypertens Rep. 2019;21(1):4. doi:10.1007/s11906-019-0907-1
   PubMed Web of Science ®Google Scholar
• Ahadzadeh E, Rosendahl A, Czesla D, et al. The chemokine receptor CX3CR1 reduces renal injury in mice with angiotensin II-induced hypertension. Am J Physiol Renal Physiol. 2018;315(6):F1526–F1535. doi:10.1152/ajprenal.00149.2018
   PubMed Web of Science ®Google Scholar
• Bagci B, Bagci G, Huzmeli C, Sezgin I, Ozdemir O. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis. Int Urol Nephrol. 2016;48(7):1163–1170. doi:10.1007/s11255-016-1293-0
   PubMed Web of Science ®Google Scholar
• Wu YB, Zang WD, Yao WZ, et al. Analysis of FOS, BTG2, and NR4A in the function of renal medullary hypertension. GMR. 2013;12(3):3735–3741. doi:10.4238/2013.September.19.4
   PubMed Web of Science ®Google Scholar
• Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2):S41–S52. doi:10.1016/j.jaci.2009.09.046
   PubMed Web of Science ®Google Scholar
• Lefranc MP. Immunoglobulin and T-cell receptor genes: IMGT ((R)) and the birth and rise of immunoinformatics. Front Immunol. 2014;5:22. doi:10.3389/fimmu.2014.00022
   PubMed Web of Science ®Google Scholar
• Braathen R, Hohman VS, Brandtzaeg P, Johansen FE. Secretory antibody formation: conserved binding interactions between J chain and polymeric Ig receptor from humans and amphibians. J Immunol. 2007;178(3):1589–1597. doi:10.4049/jimmunol.178.3.1589
   PubMed Web of Science ®Google Scholar
• Sugimura K, Fukumoto Y, Nawata J, et al. Hypertension promotes phosphorylation of focal adhesion kinase and proline-rich tyrosine kinase 2 in rats: implication for the pathogenesis of hypertensive vascular disease. Tohoku J Exp Med. 2010;222(3):201–210. doi:10.1620/tjem.222.201
   PubMed Web of Science ®Google Scholar
• Cheng PW, Lee HC, Lu PJ, et al. Resveratrol inhibition of Rac1-derived reactive oxygen species by AMPK decreases blood pressure in a fructose-induced rat model of hypertension. Sci Rep. 2016;6(1):25342. doi:10.1038/srep25342
   PubMed Web of Science ®Google Scholar
• Sereti E, Stamatelopoulos KS, Zakopoulos NA, Evangelopoulou A, Mavragani CP, Evangelopoulos ME. Hypertension: an immune related disorder? Clin Immunol. 2020;212:108247. doi:10.1016/j.clim.2019.108247
   PubMed Web of Science ®Google Scholar
• Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the immune system in hypertension. Physiol Rev. 2017;97(3):1127–1164. doi:10.1152/physrev.00031.2016
   PubMed Web of Science ®Google Scholar
• Kasal DA, Barhoumi T, Li MW, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension. 2012;59(2):324–330. doi:10.1161/HYPERTENSIONAHA.111.181123
   PubMed Web of Science ®Google Scholar
• Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009;119(22):2904–2912. doi:10.1161/CIRCULATIONAHA.108.832782
   PubMed Web of Science ®Google Scholar
• Matrougui K, Abd Elmageed Z, Kassan M, et al. Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol. 2011;178(1):434–441. doi:10.1016/j.ajpath.2010.11.034
   PubMed Web of Science ®Google Scholar
• Barhoumi T, Kasal DA, Li MW, et al. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension. 2011;57(3):469–476. doi:10.1161/HYPERTENSIONAHA.110.162941
   PubMed Web of Science ®Google Scholar
• Youn JC, Yu HT, Lim BJ, et al. Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension. 2013;62(1):126–133. doi:10.1161/HYPERTENSIONAHA.113.00689
   PubMed Web of Science ®Google Scholar
• Ferguson JF, Aden LA, Barbaro NR, et al. High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension. JCI Insight. 2019;5. doi:10.1172/jci.insight.126241
   Web of Science ®Google Scholar
• Lu X, Rudemiller NP, Wen Y, et al. A20 in myeloid cells protects against hypertension by inhibiting dendritic cell-mediated T-cell activation. Circ Res. 2019;125(12):1055–1066. doi:10.1161/CIRCRESAHA.119.315343
   PubMed Web of Science ®Google Scholar
• Kirabo A, Fontana V, de Faria AP, et al. DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest. 2014;124(10):4642–4656. doi:10.1172/JCI74084
   PubMed Web of Science ®Google Scholar
• Acelajado MC, Hughes ZH, Oparil S, Calhoun DA. Treatment of resistant and refractory hypertension. Circ Res. 2019;124(7):1061–1070. doi:10.1161/CIRCRESAHA.118.312156
   PubMed Web of Science ®Google Scholar
• Parreira RC, Lacerda LHG, Vasconcellos R, et al. Decoding resistant hypertension signalling pathways. Clin Sci. 2017;131(23):2813–2834. doi:10.1042/CS20171398
   Web of Science ®Google Scholar
• Kara SP, Ozkan G, Yilmaz A, Bayrakci N, Guzel S, Geyik E. MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone. Ren Fail. 2021;43(1):676–683. doi:10.1080/0886022X.2021.1915800
   PubMed Web of Science ®Google Scholar